Life Science Big News Roundup: Biocure Signs a Collaboration Agreement with Y Biologics; PreveCeutical Provides Update on the Dual Gene Therapy Program; Lexaria Partners with Altria to Fund Research and Development of DehydraTECH(tm) Technology

In case you missed it, here is this week’s life science big news roundup:

Biotech:

To see our previous Life Science Investing Big News Roundups, please click here.

Learn to invest in life science and medical stocks

 

Read your free report today

 

The post Life Science Big News Roundup: Biocure Signs a Collaboration Agreement with Y Biologics; PreveCeutical Provides Update on the Dual Gene Therapy Program; Lexaria Partners with Altria to Fund Research and Development of DehydraTECH(tm) Technology appeared first on Investing News Network.

Investing News Network

, , , , , , , , , , , , , , , , , , , , , , ,

Comments are closed.